stacking semaglutide and retatrutide Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide and Semaglutide Together: Safety

Long-term side effects of Wegovy Side effects that can affect your health long-term are also possible, although they are rare and some have only been seen in animal trials

Hold the vial up to a light source and look for any of these warning signs: Cloudiness or haziness

The medication maintains identical quality standards while offering increased accessibility for patients seeking treatment options

Common side effects shared by both medications: Nausea (most common, usually transient peaks during dose escalation) Vomiting Diarrhea or constipation Decreased appetite and early satiety Bloating or stomach discomfort Injection site reactions Key safety warnings that apply to both drugs: FDA Boxed Warning (both): Possible risk of thyroid C-cell tumors, based on animal studies